PC
SRRA

Paulson & Co’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Paulson & Co’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,675
Closed -$972K – 34
2022
Q2 		$972K Buy
+17,675
New +$927K 0.05% 31

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Paulson & Co's SRRA Position: Q3 2022 in Review

Paulson & Co sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 17,675 shares — an estimated $972K sold.

Paulson & Co first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $972K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Paulson & Co reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Paulson & Co sold 17,675 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $972K.
  • Paulson & Co first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Paulson & Co's Sierra Oncology, Inc. Common Stock position peaked at $972K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Paulson & Co's 13F filing for Q3 2022, filed 14 Nov 2022.